Amlobika HCT Tablet 5/20/12.5 Milligrams

Adult dose

This medication should be taken once daily with water, regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning) if possible. The recommended dosages can be adjusted from 5/20/12.5mg to 10/40/25mg depending on the patient’s blood pressure control state. The maximum dose is Amlodipine/Olmesartan Medoxomil/Hydrochlorothiazide 10/40/25mg. Patients with renal impairment, hepatic impairment

Child dose

Safety and effectiveness have not been established for pediatric patients under 18 years of age; therefore, administration of this drug is not recommended.

This drug can cause serious harm to the fetus and newborn during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. It should not be administered to patients allergic to this drug or its components, those with specific heart, kidney, or liver diseases, pregnant or breastfeeding women, and patients with severe hypotension. Adequate observation and measures are necessary before treatment for patients with reduced blood volume or sodium, as hypotension may occur. Patients with decreased kidney function or kidney transplant recipients should have their kidney function periodically tested while taking this drug. It is recommended to avoid using this drug in patients with severe liver dysfunction or bile duct diseases. Elderly patients or those with certain cardiovascular diseases may have heightened sensitivity to the drug's effects and should be administered with caution. This drug lowers blood pressure and may cause dizziness or hypotension; caution is necessary when driving or operating dangerous machinery. There may be interactions with other medications taken alongside this one, so it is essential to inform the doctor or pharmacist of any other medications being used. In case of overdose, symptoms such as hypotension and palpitations may occur, and immediate medical attention should be sought. Safety and effectiveness of this medication in children have not been established, so it is not recommended for use in this population. Store this medication out of reach of children and avoid moisture and direct sunlight.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain of oral/eye mucous membranes, difficulty breathing or shortness of breath, asthma attacks, cough accompanied by fever indicating respiratory issues, yellowing of skin or eyes (jaundice), extreme fatigue throughout the body, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, urination

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory infection
• nasopharyngitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication should be stored in a tightly closed container to avoid exposure to air or moisture, and it is recommended to keep it at room temperature between 1 and 30 degrees Celsius. Storing it this way maintains the drug's effectiveness and ensures its safe use.

Appearance

White-orange round film-coated tablet

Package unit

28 Tablets (14 Tablets/PTP * 2)